We are live on ! Find out more
MTEM

Molecular Templates, Inc.

Delisted

MTEM was delisted on the 24th of December, 2024.

36 hedge funds and large institutions have $43.6M invested in Molecular Templates, Inc. in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

63% more capital invested

Capital invested by funds: $26.9M → $43.6M (+$16.8M)

24% more funds holding

Funds holding: 2936 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
36
Holders Change
+7
Holders Change %
+24.14%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
10
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change

MTEM Hedge Fund Activity: Q4 2017 in Review

36 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2017, worth a combined $43.6M — up 63% from $26.9M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MTEM positions and 4 closed out — a net gain of 7 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was International Biotechnology Trust, adding an estimated $1.67M. The largest seller was Vanguard Group, cutting an estimated $219K.

  • 36 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2017, up from 29 in Q3 2017.
  • Funds reported $43.6M of Molecular Templates, Inc. stock for Q4 2017, up 63% quarter-over-quarter.
  • 11 funds opened new Molecular Templates, Inc. positions in Q4 2017 and 4 closed out, a net change of +7 holders.
  • The largest Molecular Templates, Inc. buyer in Q4 2017 was International Biotechnology Trust, an estimated $1.67M added.
  • The largest Molecular Templates, Inc. seller in Q4 2017 was Vanguard Group, an estimated $219K sold.

Based on aggregated 13F filings for Q4 2017.